Citation Impact

Citing Papers

Les endocardites infectieuses chez l’enfant africain subsaharien, étude transversale à propos de 19 cas à Ouagadougou au Burkina Faso
2013
Recurrent cutaneous leishmaniasis: A role for persistent parasites?
1994
Leishmaniasis
2018 Standout
Nocardiosis: Updates and Clinical Overview
2012 Standout
Immunologic Markers of Clinical Evolution in Children Recently Infected with Leishmania donovani chagasi
1992
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Recurrent lesions in human Leishmania braziliensis infection—reactivation or reinfection?
1990
Leishmaniasis in immunosuppressed individuals
2014
Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.
1998
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature
2005
Interferon-γ therapy in AIDS for mononuclear phagocyte activation
1990
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Cutaneous leishmaniasis
2007 Standout
Yersinia Enterocolitica
1989
Visceral Infection Caused by Leishmania tropica in Veterans of Operation Desert Storm
1993
Nocardial Infection as a Complication of HIV in So uth Africa
2000
Effective clearance of intracellular Leishmania majorin vivo requires Pten in macrophages
2008 StandoutNobel
Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.
1989
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
Nocardiosis at the Turn of the Century
2009 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Infective endocarditis in congenital heart disease
2011
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis
2003
Yersinia enterocolitica Infection with Multiple Liver Abscesses Uncovering a Primary Hemochromatosis
2001
Tumor necrosis factor signaling
2003 Standout
Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects
2005 StandoutNobel
Opportunistic infections in AIDS in developed and developing countries
1990
Visceral leishmaniasis control: a public health perspective
2000
INFECTIVE ENDOCARDITIS IN CONGENITAL HEART DISEASE
1996
Complications Associated with Brucella melitensis Infection: A Study of 530 Cases
1996 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Host Factors in the Severity of Q Fever
1990
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
1996
Severe falciparum malaria
2004 Standout
Cancer incidence in a cohort of human immunodeficiency virus seroconverters
1997
Infection in Organ-Transplant Recipients
1998 Standout
Reports of 355 transfusion‐associated deaths: 1976 through 1985
1990 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Leishmaniasis
1999 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Visceral Leishmaniasis in a Renal Transplant Recipient
1998
The Role of Iron Overload in Yersinia enterocolitica and Yersinia pseudotuberculosis Bacteremia in Hemodialysis Patients
1987
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Yersinia-induced Apoptosis In Vivo Aids in the Establishment of a Systemic Infection of Mice
1998
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani
1995
Phagocytic cell function in active brucellosis
1994
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Q Fever
1999 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
PNEUMOCYSTIS CARINII AND PARASITIC INFECTIONS IN TRANSPLANTATION
1995
Advances in leishmaniasis
2005 Standout
Tumor Necrosis Factor Receptor p55-Deficient Mice Respond to AcuteYersinia enterocoliticaInfection with Less Apoptosis and More Effective Host Resistance
2000
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.
1991
Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine
1993
Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells
2005 Standout
Nocardia species: host-parasite relationships
1994 Standout
Infective Endocarditis in Children With Congenital Heart Disease
2013
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Effects of iron and desferrioxamine on infections with Yersinia enterocolitica
1985
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation inLeishmania donovani-Infected Macrophages
2006
Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control
2006 Standout
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica
2011

Works of Luís Buzón being referenced

[Functional changes in the leukocytes in brucellosis].
1985
Visceral leishmaniasis in immunocompromised hosts
1987
Infectious endocarditis in children
1990
Cutaneous Nocardiosis and Human Immunodeficiency Virus Infection
1991
Hodgkin's disease in patients with antibodies to human immunodeficiency virus a study of 22 patients
1990
[Cutaneous and systemic leishmaniasis with a herpesvirus infection in an AIDS patient].
1990
Yersinia enterocolitica Septicemia
1980
Rankless by CCL
2026